AN OBSERVATIONAL STUDY TO COLLECT FOLLOW-UP CLINICAL DATA FROM KIDNEY TRANSPLANT RECIPIENTS WHO RECEIVED TOFACITINIB (CP-690,550) IN COMPLETED PHASE 2 STUDIES
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2014
At a glance
- Drugs Tofacitinib (Primary) ; Immunosuppressants
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 23 Jul 2012 Actual end date (Jul 2012) added as reported by ClinicalTrials.gov.
- 23 Jul 2012 Actual patient number changed from 110 to 94 according to ClinicalTrials.gov.
- 07 Jul 2012 Planned end date changed from 1 Jun 2012 to 1 Jul 2012 as reported by ClinicalTrials.gov.